Beloteca, Inc. Opens Product Development Laboratory In San Diego, California
10/28/2015
According to company officials, “Beloteca's primary focus is to develop and obtain regulatory approval for sterile pharmaceutical products with an emphasis on generics and 505(b)(2) reformulations. We target niche and difficult to manufacture products.”
"This new laboratory helps Beloteca achieve its mission of developing multiple products per year," said Fred Defesche, CEO of Beloteca, Inc. "It also allows Beloteca to take greater control over project timelines and the development process."
"The new laboratory establishes Beloteca's in-house product development capabilities allowing the evaluation of development projects prior to initiating full development creating a more nimble and aggressive approach to project selection. Additionally, the new laboratory will be used for many of Beloteca's analytical and formulation development activities enabling Beloteca to develop many of its products in house," stated Dorla Mirejovsky, CFO of Beloteca.
Project Announcements
Fukoku Korea Plans Henry County, Virginia, Manufacturing Operations
03/13/2026
Germany-Based Sennheiser Group Plans Nashville, Tennessee, Operations
03/12/2026
Interstate Group Expands Giles County, Virginia, Production Operations
03/11/2026
Shinhwa Auto USA Expands Auburn, Alabama, Operations
03/11/2026
General Atomics Expands Shannon, Mississippi, Production Operations
03/11/2026
Starbucks Plans Davidson County, Tennessee, Corporate Operations
03/08/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025
-
Amazon’s First Mass Timber Delivery Station Tests the Future of Low-Carbon Logistics
Q4 2025